Walgreens is intensifying its focus on automation as it navigates challenges facing the retail pharmacy sector. The company is expanding its network of micro-fulfillment centers, which use robotics to process millions of prescriptions monthly for conditions like diabetes and hypertension. These centers aim to streamline pharmacy operations, cut inventory waste, and allow store staff to concentrate on clinical services such as vaccinations and health testing.
Initially launched in 2021, Walgreens paused expansion in 2023 to improve performance and address feedback. With updated internal tools and optimized processes, the company is resuming growth, targeting over 5,000 stores by year’s end—up from 4,800 in February. These facilities currently handle about 40% of prescription volume across supported locations, filling around 16 million prescriptions monthly.
The renewed automation drive coincides with Walgreens’ planned $10 billion privatization deal with Sycamore Partners. The move follows a period marked by declining pharmacy reimbursements, pandemic-related challenges, store closures, and growing competition from digital players and other retail giants.
Pharmacy staff have expressed discontent with overwork and understaffing, which led to nationwide walkouts in 2023. The automation strategy directly addresses these concerns by alleviating workload and enabling pharmacists to spend more time with patients. According to Walgreens executives, stores served by micro-fulfillment centers administer 40% more vaccines and have helped save the company roughly $500 million by reducing excess inventory and improving efficiency.
Each fulfillment site features a sophisticated robotic system that automates pill dispensing. Human staff fill medication canisters, which are then used by robot arms to accurately fill labeled vials. Some prescriptions, such as inhalers or pill packs, are processed manually and then sorted for delivery to retail locations. Built-in security features prevent errors, and employees are extensively trained to ensure patient safety.
In response to feedback, Walgreens is transitioning to smaller vials to reduce shipping costs and allow more prescriptions per order. Additionally, new tools enable real-time tracking of prescription status, enhancing customer service.
Although some incidents of delays or incomplete fills have been reported, Walgreens leadership sees this system as foundational for future growth, including potential direct-to-home delivery. The company also reported a 126% year-over-year increase in prescription volume, now exceeding 170 million annually, with ambitions to surpass 180 million.
READ MORE: